From Gestational Hypertension and Preeclampsia to Atypical Hemolytic Uremic Syndrome
- PMID: 27054930
- DOI: 10.1097/AOG.0000000000001340
From Gestational Hypertension and Preeclampsia to Atypical Hemolytic Uremic Syndrome
Abstract
Background: Preeclampsia is a leading cause of morbidity and mortality during pregnancy. The variability of clinical features suggests that preeclampsia is not a single disease. Atypical hemolytic uremic syndrome, resulting from defective regulation of the alternative complement pathway, is less well known and may be mistaken for preeclampsia.
Case: We describe a woman with atypical hemolytic uremic syndrome who was given the diagnosis of gestational hypertension during her first pregnancy and preeclampsia and hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome followed by thrombotic thrombocytopenic purpura and hemolytic uremic syndrome during her second pregnancy, before the correct diagnosis of atypical hemolytic uremic syndrome was recognized in the postpartum period of her third pregnancy. The patient was treated with anticomplement therapy and had a rapid improvement.
Conclusion: This case illustrates the importance of distinguishing atypical hemolytic uremic syndrome from preeclampsia.
Comment in
-
From Gestational Hypertension and Preeclampsia to Atypical Hemolytic Uremic Syndrome.Obstet Gynecol. 2016 Sep;128(3):657. doi: 10.1097/AOG.0000000000001610. Obstet Gynecol. 2016. PMID: 27548541 No abstract available.
-
In Reply.Obstet Gynecol. 2016 Sep;128(3):657-658. doi: 10.1097/AOG.0000000000001611. Obstet Gynecol. 2016. PMID: 27548542 No abstract available.
References
-
- Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007;18:2281–4.
-
- Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaimé F, Dragon-Durey MA, Ngo S, et al.. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 2013;8:554–62.
-
- Tsai HM. A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome. Transfus Med Rev 2014;28:187–97.
-
- Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al.. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992–1005.
-
- Salmon JE, Heuser C, Triebwasser M, Liszewski MK, Kavanagh D, Roumenina L, et al.. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLos Med 2011;8:e1001013.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical